| ASSET | YEAR | % RETURN |
|---|---|---|
GeneDx (WGS) | 2024 | 2,766.67% |
SoundHound AI (SOUN) | 2024 | 921.36% |
Rigetti Computing (RGTI) | 2024 | 837% |
Janux Therapeutics (JANX) | 2024 | 432.12% |
BBVA Banco Frances SA ADR (BBAR) | 2024 | 302.85% |
Ast Spacemobile (ASTS) | 2024 | 290.44% |
ADMA Biologics (ADMA) | 2024 | 286.67% |
Banco Macro SA B ADR (BMA) | 2024 | 284.25% |
IONQ (IONQ) | 2024 | 259.68% |
Nextnav Acquisition (NN) | 2024 | 252.94% |
Avidity Biosciences (RNA) | 2024 | 252.77% |
Lumen Technologies (LUMN) | 2024 | 230.73% |
Longboard Pharmaceuticals (LBPH) | 2024 | 224.57% |
PureCycle Technologies (PCTTW) | 2024 | 220.18% |
Sweetgreen (SG) | 2024 | 216.79% |
Brinker International (EAT) | 2024 | 213.11% |
Rush Street Interactive (RSI) | 2024 | 209.98% |
Hims Hers Health (HIMS) | 2024 | 197.73% |
United States Lime & Minerals (USLM) | 2024 | 194.02% |
Semtech (SMTC) | 2024 | 193.4% |
Powell Industries (POWL) | 2024 | 184% |
Edgewise Therapeutics (EWTX) | 2024 | 181.61% |
Vera Therapeutics (VERA) | 2024 | 180.26% |
Wave Life Sciences (WVE) | 2024 | 170.2% |
Purecycle Technologies (PCT) | 2024 | 168.56% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
